Huijie D. Gao

Tianjin, 300070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

CD47-SIRPα axis mediated by ncRNA correlates with poor prognosis, immune microenvironment dysregulation and lipid metabolism modulation in hepatocellular carcinoma.

CD47-SIRPα axis mediated by ncRNA correlates with poor prognosis, immune microenvironment dysregulation and lipid metabolism modulation in hepatocellular carcinoma.

Journal: International journal of biological macromolecules

Published: May 25, 2025

miR-150-5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification.

miR-150-5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification.

Journal: Molecular carcinogenesis

Published: February 16, 2025

BAMBI Is a Prognostic Biomarker Associated with Macrophage Polarization, Glycolysis, and Lipid Metabolism in Hepatocellular Carcinoma.

BAMBI Is a Prognostic Biomarker Associated with Macrophage Polarization, Glycolysis, and Lipid Metabolism in Hepatocellular Carcinoma.

Journal: International journal of molecular sciences

Published: September 25, 2024

Analysis of influenza vaccination status and immunization strategy in high-risk population

Analysis of influenza vaccination status and immunization strategy in high-risk population

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: April 28, 2024

miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of the enhancer I/X promoter.

miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of the enhancer I/X promoter.

Journal: Archives of virology

Published: June 15, 2023

The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells.

The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells.

Journal: International journal of oncology

Published: October 05, 2022

Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129].

Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129].

Journal: EBioMedicine

Published: October 31, 2021

Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells.

Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells.

Journal: Journal of Cancer

Published: September 20, 2021

Retraction Note: A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX.

Retraction Note: A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX.

Journal: Oncogenesis

Published: July 16, 2021

SEC61G plays an oncogenic role in hepatocellular carcinoma cells.

SEC61G plays an oncogenic role in hepatocellular carcinoma cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 10, 2020

Host-guest supramolecular hydrogel based on nanoparticles: co-delivery of DOX and siBcl-2 for synergistic cancer therapy.

Host-guest supramolecular hydrogel based on nanoparticles: co-delivery of DOX and siBcl-2 for synergistic cancer therapy.

Journal: Journal of biomaterials science. Polymer edition

Published: April 27, 2019

RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.

RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.

Journal: EBioMedicine

Published: April 01, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026